RxDoctor Payments Data

Stephen Gardner, MD

Orthopaedic Surgery · Mission Viejo, CANPI 1871753392

Payments from drug & device makers

$8,622in general payments, 2019–2025

Across 91 payments — averaging $94.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Arthrex$2K
  • Micromed Inc$2K
  • Smith+Nephew$867
  • Zimmer Biomet$744
  • Saxum Surgical, Inc.$302
  • plus $284 from 5 others

What the payments were for

  • Travel & lodging$1,42517%
  • Food & beverage$5,45763%
  • Education$1,74020%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker33$2,496
Arthrex24$2,189
Micromed Inc1$1,740
Smith+Nephew9$867
Zimmer Biomet14$744
Saxum Surgical, Inc.3$302
Linvatec Corporation3$183
Medtronic1$35
Johnson & Johnson1$27
Treace Medical Concepts, Inc.1$20
Acumed LLC1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,622 in reported general payments places this provider in the 65th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$401,851
Medicare patients
673
Services billed
9,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib90$2,025
Diclofenac Sodium31$464
Methylprednisolone22$276
Cephalexin62$122
Oxycodone Hcl11$59
Meloxicam13$35
Tramadol Hcl12$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Mission Viejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →